Cargando…
Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions
The initial interaction between HIV-1 and the host occurs at the mucosa during sexual intercourse. In cervical mucosa, HIV-1 exists both as free and opsonized virions and this might influence initial infection. We used cervical explants to study HIV-1 transmission, the effects of opsonization on inf...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231223/ https://www.ncbi.nlm.nih.gov/pubmed/23686382 http://dx.doi.org/10.1002/eji.201243257 |
_version_ | 1782344406408364032 |
---|---|
author | Tjomsland, Veronica Ellegård, Rada Kjölhede, Preben Wodlin, Ninni Borendal Hinkula, Jorma Lifson, Jeffrey D Larsson, Marie |
author_facet | Tjomsland, Veronica Ellegård, Rada Kjölhede, Preben Wodlin, Ninni Borendal Hinkula, Jorma Lifson, Jeffrey D Larsson, Marie |
author_sort | Tjomsland, Veronica |
collection | PubMed |
description | The initial interaction between HIV-1 and the host occurs at the mucosa during sexual intercourse. In cervical mucosa, HIV-1 exists both as free and opsonized virions and this might influence initial infection. We used cervical explants to study HIV-1 transmission, the effects of opsonization on infectivity, and how infection can be prevented. Complement opsonization enhanced HIV-1 infection of dendritic cells (DCs) compared with that by free HIV-1, but this increased infection was not observed with CD4(+) T cells. Blockage of the α4-, β7-, and β1-integrins significantly inhibited HIV-1 infection of both DCs and CD4(+) T cells. We found a greater impairment of HIV-1 infection in DCs for complement-opsonized virions compared with that of free virions when αM/β2- and α4-integrins were blocked. Blocking the C-type lectin receptor macrophage mannose receptor (MMR) inhibited infection of emigrating DCs but had no effect on CD4(+) T-cell infection. We show that blocking of integrins decreases the HIV-1 infection of both mucosal DCs and CD4(+) T cells emigrating from the cervical tissues. These findings may provide the basis of novel microbicidal strategies that may help limit or prevent initial infection of the cervical mucosa, thereby reducing or averting systemic HIV-1 infection. |
format | Online Article Text |
id | pubmed-4231223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-42312232014-12-15 Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions Tjomsland, Veronica Ellegård, Rada Kjölhede, Preben Wodlin, Ninni Borendal Hinkula, Jorma Lifson, Jeffrey D Larsson, Marie Eur J Immunol Immunity to Infection The initial interaction between HIV-1 and the host occurs at the mucosa during sexual intercourse. In cervical mucosa, HIV-1 exists both as free and opsonized virions and this might influence initial infection. We used cervical explants to study HIV-1 transmission, the effects of opsonization on infectivity, and how infection can be prevented. Complement opsonization enhanced HIV-1 infection of dendritic cells (DCs) compared with that by free HIV-1, but this increased infection was not observed with CD4(+) T cells. Blockage of the α4-, β7-, and β1-integrins significantly inhibited HIV-1 infection of both DCs and CD4(+) T cells. We found a greater impairment of HIV-1 infection in DCs for complement-opsonized virions compared with that of free virions when αM/β2- and α4-integrins were blocked. Blocking the C-type lectin receptor macrophage mannose receptor (MMR) inhibited infection of emigrating DCs but had no effect on CD4(+) T-cell infection. We show that blocking of integrins decreases the HIV-1 infection of both mucosal DCs and CD4(+) T cells emigrating from the cervical tissues. These findings may provide the basis of novel microbicidal strategies that may help limit or prevent initial infection of the cervical mucosa, thereby reducing or averting systemic HIV-1 infection. BlackWell Publishing Ltd 2013-09 2013-06-25 /pmc/articles/PMC4231223/ /pubmed/23686382 http://dx.doi.org/10.1002/eji.201243257 Text en © 2013 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA Weinheim. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Immunity to Infection Tjomsland, Veronica Ellegård, Rada Kjölhede, Preben Wodlin, Ninni Borendal Hinkula, Jorma Lifson, Jeffrey D Larsson, Marie Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions |
title | Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions |
title_full | Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions |
title_fullStr | Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions |
title_full_unstemmed | Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions |
title_short | Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions |
title_sort | blocking of integrins inhibits hiv-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions |
topic | Immunity to Infection |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231223/ https://www.ncbi.nlm.nih.gov/pubmed/23686382 http://dx.doi.org/10.1002/eji.201243257 |
work_keys_str_mv | AT tjomslandveronica blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions AT ellegardrada blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions AT kjolhedepreben blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions AT wodlinninniborendal blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions AT hinkulajorma blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions AT lifsonjeffreyd blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions AT larssonmarie blockingofintegrinsinhibitshiv1infectionofhumancervicalmucosaimmunecellswithfreeandcomplementopsonizedvirions |